The perfect storm: COVID-19, mass incarceration and the opioid epidemic
The perfect storm: COVID-19, mass incarceration and the opioid epidemic
复制标题
DOI:
10.1016/j.drugpo.2020.102819
复制
发表时间:
2020-09-01
影响因子:
4.4
通讯作者:
El-Bassel, Nabila
中科院分区:
文献类型:
--
作者:
Mukherjee, Trena I.;El-Bassel, Nabila
Overcrowding, poor hygiene, and inadequate access to medical care make correctional facilities particularly vulnerable to COVID-19. As of May 15, 2020, there have been 7671 laboratory confirmed cases, and 103 deaths among inmates and correctional staff in the United States (US)(Wallace, Hagan, & Curran, 2020), and over 56,000 cases and 987 deaths, globally (Justice Project Pakistan, 2020). In the US, jails and prisons are responsible for a large proportion of COVID-19 infections, with over 25,000 cases connected to correctional facilities to date (New York Times, 2020). People with opioid use disorders (OUDs) are disproportionately incarcerated and suffer from a number of pre-existing conditions, creating a ‘perfect storm’for a COVID-19 outbreak. Furthermore, COVID-19 capitalizes on inequity (Wang & Tang, 2020), and the epidemic of mass incarceration has resulted in a number of social, economic and health inequities. The conditions within correctional facilities make it infeasible to enact many of the World Health Organization's recommended COVID-19 prevention strategies (World Health Organization, 2020). Infection control measures like social distancing, hand washing, and quarantine are near impossible in densely populated jails and prisons, where the majority of inmates share cells and other communal spaces. Correctional facilities are also notoriously unsanitary, lack adequate ventilation or cleaning supplies, and inmates often have restricted access to soap and running water.Over a quarter of criminal justice involved populations in the US are charged with a drug offense (Rabuy, 2016), and it is estimated that 65% of the US prison population has a substance use disorder (“Behind Bars II: Substance Abuse and America’s Prison Population. New York, NY:,” 2010). Globally, it is estimated that one in six are serving time for drug possession (Burki, 2020), and between 10 and 60% have a substance use disorder (Carpentier, Royuela, Montanari, & Davis, 2018). Populations most vulnerable to COVID-19 include older adults and persons of any age with serious underlying medical conditions such as lung disease, heart disease, and diabetes. Among people who use drugs, COVID-19 infection may worsen the respiratory impact of opioid use and withdrawal, as opioids act in the brainstem to slow breathing, leading to respiratory depression and potential overdose (Boom et al., 2012). Those with substance use disorders also experience greater comorbidities, including cardiovascular disease (Thylstrup, Clausen & Hesse, 2015), or be immunocompromised due to HIV (Azbel & Altice,